Sonodynamic therapy plus chemoradiation for glioblastoma
Part of Cancer clinical trials.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have just been diagnosed with glioblastoma and have had surgery to remove the tumor.
- You are under 75 years old.
- Your blood counts, liver, and kidney function are within normal limits (checked by blood tests).
- You are expected to live at least 3 more months.
- You are not pregnant or breastfeeding, and you agree to use effective birth control during the study and for 12 months after the last treatment dose.
- You do not have other serious medical conditions like uncontrolled infections, active hepatitis, or HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a higher dose of radiation to the tumor area improves outcomes for people with glioblastoma. It is for those who have had surgery or are planned for radiation, and have some remaining tumor.
This trial tests adding a chemotherapy drug (thiotepa) directly into the spinal fluid for people with a newly diagnosed glioblastoma that has spread to the brain's lining or ventricles. It aims to see if this extra treatment can help control the cancer.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests whether adding sonodynamic therapy (a treatment that uses sound waves to activate a drug) before standard radiation and chemotherapy can help people with a type of brainstem glioma called DIPG. The goal is to see if this combination improves survival.
This trial tests a new approach that uses a light-sensitive drug and low-intensity ultrasound to make standard chemotherapy more effective for glioblastoma. If you have completed initial treatment with radiation and temozolomide without the tumor growing, you may be eligible.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.